Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Pancreatic Cancer: An Emphasis on Current Perspectives in Immunotherapy.

Patel K, Siraj S, Smith C, Nair M, Vishwanatha JK, Basha R.

Crit Rev Oncog. 2019;24(2):105-118. doi: 10.1615/CritRevOncog.2019031417.

PMID:
31679206
2.

Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.

Ascierto PA, Agarwala S, Botti G, Cesano A, Ciliberto G, Davies MA, Demaria S, Dummer R, Eggermont AM, Ferrone S, Fu YX, Gajewski TF, Garbe C, Huber V, Khleif S, Krauthammer M, Lo RS, Masucci G, Palmieri G, Postow M, Puzanov I, Silk A, Spranger S, Stroncek DF, Tarhini A, Taube JM, Testori A, Wang E, Wargo JA, Yee C, Zarour H, Zitvogel L, Fox BA, Mozzillo N, Marincola FM, Thurin M.

J Transl Med. 2016 Nov 15;14(1):313.

3.

Immunotherapy in head and neck cancer: aiming at EXTREME precision.

Szturz P, Vermorken JB.

BMC Med. 2017 Jun 2;15(1):110. doi: 10.1186/s12916-017-0879-4.

4.

Evolution of checkpoint inhibitors for the treatment of metastatic gastric cancers: Current status and future perspectives.

Taieb J, Moehler M, Boku N, Ajani JA, Yañez Ruiz E, Ryu MH, Guenther S, Chand V, Bang YJ.

Cancer Treat Rev. 2018 May;66:104-113. doi: 10.1016/j.ctrv.2018.04.004. Epub 2018 Apr 22. Review.

5.

The next generation of immunotherapy: keeping lung cancer in check.

Somasundaram A, Burns TF.

J Hematol Oncol. 2017 Apr 24;10(1):87. doi: 10.1186/s13045-017-0456-5. Review.

6.

Immunotherapy in Urothelial Cancer: Recent Results and Future Perspectives.

Farina MS, Lundgren KT, Bellmunt J.

Drugs. 2017 Jul;77(10):1077-1089. doi: 10.1007/s40265-017-0748-7. Review.

PMID:
28493171
7.

New Approaches for Immune Directed Treatment for Ovarian Cancer.

Hardwick N, Frankel PH, Cristea M.

Curr Treat Options Oncol. 2016 Mar;17(3):14. doi: 10.1007/s11864-016-0389-1. Review.

PMID:
26942589
8.

Perspectives on Treatment of Metastatic Colorectal Cancer with Immune Checkpoint Inhibitor Therapy.

Morse MA, Hochster H, Benson A.

Oncologist. 2019 Aug 5. pii: theoncologist.2019-0176. doi: 10.1634/theoncologist.2019-0176. [Epub ahead of print] Review.

PMID:
31383813
9.

Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis.

Yu Y, Zeng D, Ou Q, Liu S, Li A, Chen Y, Lin D, Gao Q, Zhou H, Liao W, Yao H.

JAMA Netw Open. 2019 Jul 3;2(7):e196879. doi: 10.1001/jamanetworkopen.2019.6879.

10.

Development of immune checkpoint inhibitors.

Kitano S.

Rinsho Ketsueki. 2017;58(8):966-976. doi: 10.11406/rinketsu.58.966. Japanese.

PMID:
28883282
11.

Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects.

Jia H, Truica CI, Wang B, Wang Y, Ren X, Harvey HA, Song J, Yang JM.

Drug Resist Updat. 2017 May;32:1-15. doi: 10.1016/j.drup.2017.07.002. Epub 2017 Aug 19. Review.

PMID:
29145974
13.

From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?

Madden DL.

Curr Oncol Rep. 2018 Feb 7;20(1):8. doi: 10.1007/s11912-018-0662-5. Review.

PMID:
29411148
14.

A Phase II Study of Pelareorep (REOLYSIN®) in Combination with Gemcitabine for Patients with Advanced Pancreatic Adenocarcinoma.

Mahalingam D, Goel S, Aparo S, Patel Arora S, Noronha N, Tran H, Chakrabarty R, Selvaggi G, Gutierrez A, Coffey M, Nawrocki ST, Nuovo G, Mita MM.

Cancers (Basel). 2018 May 25;10(6). pii: E160. doi: 10.3390/cancers10060160.

15.

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016.

Ascierto PA, Daniele B, Hammers H, Hirsh V, Kim J, Licitra L, Nanda R, Pignata S.

J Transl Med. 2017 Oct 11;15(1):205. doi: 10.1186/s12967-017-1309-2.

16.

Immunotherapy in Bladder Cancer.

Konala VM, Adapa S, Aronow WS.

Am J Ther. 2019 Feb 28. doi: 10.1097/MJT.0000000000000934. [Epub ahead of print]

PMID:
30839322
17.
18.

The Future of Immunotherapy in the Treatment of Small Cell Lung Cancer.

Horn L, Reck M, Spigel DR.

Oncologist. 2016 Aug;21(8):910-21. doi: 10.1634/theoncologist.2015-0523. Epub 2016 Jun 27. Review.

19.

Combination Immunotherapy Approaches for Pancreatic Cancer Treatment.

Cheng X, Zhao G, Zhao Y.

Can J Gastroenterol Hepatol. 2018 Mar 7;2018:6240467. doi: 10.1155/2018/6240467. eCollection 2018. Review.

20.

Targeting the PD-1 pathway: a new hope for gastrointestinal cancers.

Bilgin B, Sendur MA, Bülent Akıncı M, Şener Dede D, Yalçın B.

Curr Med Res Opin. 2017 Apr;33(4):749-759. doi: 10.1080/03007995.2017.1279132. Epub 2017 Jan 31. Review.

PMID:
28055269

Supplemental Content

Support Center